Show simple item record

dc.contributor.authorBenito Vicente, Asier
dc.contributor.authorBelloso Uribe, Kepa
dc.contributor.authorJebari Benslaiman, Shifa
dc.contributor.authorGalicia García, Unai
dc.contributor.authorOstolaza Echabe, Elena Amaya
dc.contributor.authorMartín Plágaro, César Augusto
dc.date.accessioned2019-04-01T11:30:14Z
dc.date.available2019-04-01T11:30:14Z
dc.date.issued2018-11-01
dc.identifier.citationInternational Journal Of Molecular Sciences 19(11) : (2018) // Article ID 3426es_ES
dc.identifier.issn1422-0067
dc.identifier.urihttp://hdl.handle.net/10810/32290
dc.description.abstractCholesterol is an essential component of cell barrier formation and signaling transduction involved in many essential physiologic processes. For this reason, cholesterol metabolism must be tightly controlled. Cell cholesterol is mainly acquired from two sources: Dietary cholesterol, which is absorbed in the intestine and, intracellularly synthesized cholesterol that is mainly synthesized in the liver. Once acquired, both are delivered to peripheral tissues in a lipoprotein dependent mechanism. Malfunctioning of cholesterol metabolism is caused by multiple hereditary diseases, including Familial Hypercholesterolemia, Sitosterolemia Type C and Niemann-Pick Type C1. Of these, familial hypercholesterolemia (FH) is a common inherited autosomal co-dominant disorder characterized by high plasma cholesterol levels. Its frequency is estimated to be 1:200 and, if untreated, increases the risk of premature cardiovascular disease. This review aims to summarize the current knowledge on cholesterol metabolism and the relation of FH to cholesterol homeostasis with special focus on the genetics, diagnosis and treatment.es_ES
dc.description.sponsorshipThis work was supported by ELKARTEK 2016 and the Basque Government (Grupos Consolidados IT849-13). A.B.-V. and S.J. were supported by a grant PIF (2014-2015) and (2018-2021), Gobierno Vasco respectively.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectcholesteroles_ES
dc.subjectmetabolismes_ES
dc.subjectfamilial hypercholesterolemiaes_ES
dc.subjectdensity-lipoprotein-receptores_ES
dc.subjectsterol-sensing domaines_ES
dc.subjectApo-B mutationses_ES
dc.subjectLDL receptores_ES
dc.subjectfunctional-characterizationes_ES
dc.subjectintracellular traffickinges_ES
dc.subjectchylomicron uptakees_ES
dc.subjectABCA1 expressiones_ES
dc.subjectEGF-Aes_ES
dc.subjectPCSK9es_ES
dc.titleFamilial Hypercholesterolemia: The Most Frequent Cholesterol Metabolism Disorder Caused Diseasees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holderThis is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://www.mdpi.com/1422-0067/19/11/3426es_ES
dc.identifier.doi10.3390/ijms19113426
dc.departamentoesBioquímica y biología moleculares_ES
dc.departamentoeuBiokimika eta biologia molekularraes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Except where otherwise noted, this item's license is described as This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).